Equities
Health CareHealth Care Equipment & Services
  • Price (GBX)1,569.50
  • Today's Change-22.50 / -1.41%
  • Shares traded511.41k
  • 1 Year change-17.02%
  • Beta0.6427
Data delayed at least 20 minutes, as of Aug 14 2020 15:20 BST.
More ▼

Key statistics

As of last trade Smith & Nephew PLC (SN.:LSE) traded at 1,569.50, -22.42% below its 52-week high of 2,023.00, set on Feb 20, 2020.
52-week range
Today
1,055.01Mar 18 20202,023.00Feb 20 2020
Markit short selling activity
Low
Med
High
Open1,587.50
High1,593.00
Low1,550.50
Bid1,569.00
Offer1,569.50
Previous close1,592.00
Average volume1.56m
Shares outstanding875.59m
Free float872.81m
P/E (TTM)46.50
Market cap13.91bn GBP
EPS (TTM)0.3415
GBP
Annual div (ADY)29.42
GBX
Annual div yield (ADY)1.85%
Div ex-dateApr 02 2020
Div pay-dateMay 06 2020
Next div ex-dateOct 01 2020
Next div pay-dateOct 28 2020
Data delayed at least 20 minutes, as of Aug 14 2020 15:20 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Smith & Nephew PLC shares was Hold at 1,566.00 on 29 Jul 2020Read the full article
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.